The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other ...

The US Food and Drug Administration (FDA) has granted clearance for Roche's Elecsys pTau181 test, a blood-based biomarker ...

Elecsys’ approval could help boost the uptake of currently approved Alzheimer’s disease therapies, including Biogen’s ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the United States Food and Drug Administration (FDA) has cleared its ...

Recent Food and Drug Administration approval of the first two blood tests used in detecting Alzheimer’s disease brings hope ...

Simple blood test gets green light by FDA to improve early detection of Alzheimer’s disease - Millions of Americans are living with Alzheimer’s and hundreds of thousands are diagnosed each year ...

The blood-based biomarker test measures Tau protein phosphorylated at threonine 181 in human plasma (pTau181).

Roche Diagnostics said on Monday the U.S. Food and Drug Administration cleared its and partner Eli Lilly's blood test as an ...

Dear Savvy Senior, Are there any proven strategies to preventing cognitive decline? I have a family history of dementia and worry about my own memory and cognitive abilities as I grow older. — ...

The study, published in The Lancet Healthy Longevity, looked at data from 9,436 people aged 40 or over (with an average age ...

NeuroVISION was the study that put perioperative covert strokes on the map in 2019. That report found a 7% rate of these ...